Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile.
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), PepGen (NASDAQ:PEPG) and Abpro Hldgs (NASDAQ:ABP).
Editas Medicine has a consensus price target of $10.37.
The stock price for Editas Medicine (NASDAQ: EDIT) is $1.3063 last updated December 20, 2024 at 6:11 PM EST.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.